TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii):
International Biotechnology Trust plc
2. Reason for the notification (please place an X inside the appropriate bracket/s):
An acquisition or disposal of voting rights:()
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ()
An event changing the breakdown of voting rights: (X)
Other (please specify): ()
3. Full name of person(s) subject to the notification obligation (iii):
Reed Elsevier Pension Trustee Limited
4. Full name of shareholder(s) (if different from 3.) (iv):
Chase Nominees Limited a/c REPS
5. Date of the transaction (and date on which the threshold is crossed or reached if different) (v):
27 February 2009
6. Date on which issuer notified:
9 October 2009
7. Threshold(s) that is/are crossed or reached:
3%
8. Notified details:
A: Voting rights attached to shares
Class/type of shares if possible using the ISIN CODE |
Situation previous to the triggering transaction (vi) |
|
|
Number of shares |
Number of voting Rights (viii) |
Ordinary Share GB0004559349 |
1,961,906 |
1,961,906 |
Resulting situation after the triggering transaction (vii)
Class/type of shares if possible using the ISIN CODE |
Number of shares |
Number of voting rights (ix) |
% of voting rights |
||
|
Direct |
Direct (x) |
Indirect (xi) |
Direct |
Indirect |
Ordinary GB0004559349 |
1,961,906 |
1,961,906 |
- |
1,961,906 |
- |
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction (xii)
Type of financial instrument |
Expiration Date (xiii) |
Exercise/Conversion Period/ Date (xiv) |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
% of voting rights |
N/A |
N/A |
N/A |
N/A |
N/A |
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction (xii)
Type of financial instrument |
Exercise price |
Expiration Date |
Exercise/Conversion Period |
Number of voting rights instrument refers to |
% of voting rights |
N/A |
|
N/A |
N/A |
N/A |
Nominal DeltaA |
Total (A+B)
Number of voting rights |
% of voting rights |
1,961,906 |
3.03% |
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xv):
N/A
Proxy Voting:
10. Name of the proxy holder:
N/A
11. Number of voting rights proxy holder will cease to hold:
N/A
12. Date on which proxy holder will cease to hold voting rights:
N/A
13. Additional information:
14. Contact name for queries on this announcement:
Thomas Bourke
15. Contact telephone number:
020 7166 5694
Date: 9 OCTOBER 2009